Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett’s oesophagus related neoplasia

Darina KohoutovaDivision of Surgery & Interventional Science, University College London, London, UK; ;Division of GI Services, University College London Hospital, London, UK; Correspondence[email protected]

Rehan HaidryDivision of Surgery & Interventional Science, University College London, London, UK; ;Division of GI Services, University College London Hospital, London, UK;

Matthew BanksDivision of Surgery & Interventional Science, University College London, London, UK; ;Division of GI Services, University College London Hospital, London, UK;

Mohammed Adil ButtDivision of Surgery & Interventional Science, University College London, London, UK; ;Division of GI Services, University College London Hospital, London, UK;

Jason DunnGuy's and St Thomas' NHS Foundation Trust, London, UK

Sally ThorpeDivision of GI Services, University College London Hospital, London, UK;

Laurence LovatDivision of Surgery & Interventional Science, University College London, London, UK; ;Division of GI Services, University College London Hospital, London, UK; Correspondence[email protected]

show all

Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett’s oesophagus related neoplasia

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett’s oesophagus related neoplasia

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date